Made to order: emergency myelopoiesis and demand-adapted innate immune cell production.

Orkin, S. H. & Zon, L. I. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132, 631–644 (2008).

pubmed: 18295580 pmcid: 2628169 doi: 10.1016/j.cell.2008.01.025

Wilson, A. et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135, 1118–1129 (2008).

pubmed: 19062086 doi: 10.1016/j.cell.2008.10.048

Schoedel, K. B. et al. The bulk of the hematopoietic stem cell population is dispensable for murine steady-state and stress hematopoiesis. Blood 128, 2285–2296 (2016).

pubmed: 27357698 doi: 10.1182/blood-2016-03-706010

Rodriguez-Fraticelli, A. E. et al. Clonal analysis of lineage fate in native haematopoiesis. Nature 553, 212–216 (2018).

pubmed: 29323290 pmcid: 5884107 doi: 10.1038/nature25168

Sun, J. et al. Clonal dynamics of native haematopoiesis. Nature 514, 322–327 (2014).

pubmed: 25296256 pmcid: 4408613 doi: 10.1038/nature13824

Pietras, E. M. et al. Functionally distinct subsets of lineage-biased multipotent progenitors control blood production in normal and regenerative conditions. Cell Stem Cell 17, 35–46 (2015).

pubmed: 26095048 pmcid: 4542150 doi: 10.1016/j.stem.2015.05.003

Cabezas-Wallscheid, N. et al. Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis. Cell Stem Cell 15, 507–522 (2014).

pubmed: 25158935 doi: 10.1016/j.stem.2014.07.005

Kang, Y. A., Pietras, E. M. & Passegue, E. Deregulated notch and Wnt signaling activates early-stage myeloid regeneration pathways in leukemia. J. Exp. Med. 217, e20190787 (2020).

doi: 10.1084/jem.20190787

Sommerkamp, P. et al. Mouse multipotent progenitor 5 cells are located at the interphase between hematopoietic stem and progenitor cells. Blood 137, 3218–3224 (2021).

pubmed: 33754628 pmcid: 8351880 doi: 10.1182/blood.2020007876

Akashi, K., Traver, D., Miyamoto, T. & Weissman, I. L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404, 193–197 (2000).

pubmed: 10724173 doi: 10.1038/35004599

Kondo, M., Weissman, I. L. & Akashi, K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91, 661–672 (1997).

pubmed: 9393859 doi: 10.1016/S0092-8674(00)80453-5

Till, J. E. & McCulloch, E. A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14, 213–222 (1961).

pubmed: 13776896 doi: 10.2307/3570892

Spangrude, G. J., Heimfeld, S. & Weissman, I. L. Purification and characterization of mouse hematopoietic stem cells. Science 241, 58–62 (1988).

pubmed: 2898810 doi: 10.1126/science.2898810

Muller-Sieburg, C. E., Whitlock, C. A. & Weissman, I. L. Isolation of two early B lymphocyte progenitors from mouse marrow: a committed pre-pre-B cell and a clonogenic Thy-1-lo hematopoietic stem cell. Cell 44, 653–662 (1986).

pubmed: 2868799 doi: 10.1016/0092-8674(86)90274-6

Oguro, H., Ding, L. & Morrison, S. J. SLAM family markers resolve functionally distinct subpopulations of hematopoietic stem cells and multipotent progenitors. Cell Stem Cell 13, 102–116 (2013).

pubmed: 23827712 pmcid: 3736853 doi: 10.1016/j.stem.2013.05.014

Muller-Sieburg, C. E., Cho, R. H., Karlsson, L., Huang, J. F. & Sieburg, H. B. Myeloid-biased hematopoietic stem cells have extensive self-renewal capacity but generate diminished lymphoid progeny with impaired IL-7 responsiveness. Blood 103, 4111–4118 (2004).

pubmed: 14976059 doi: 10.1182/blood-2003-10-3448

Muller-Sieburg, C. E., Cho, R. H., Thoman, M., Adkins, B. & Sieburg, H. B. Deterministic regulation of hematopoietic stem cell self-renewal and differentiation. Blood 100, 1302–1309 (2002).

pubmed: 12149211 doi: 10.1182/blood.V100.4.1302.h81602001302_1302_1309

Dykstra, B. et al. Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell 1, 218–229 (2007).

pubmed: 18371352 doi: 10.1016/j.stem.2007.05.015

Morita, Y., Ema, H. & Nakauchi, H. Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J. Exp. Med. 207, 1173–1182 (2010).

pubmed: 20421392 pmcid: 2882827 doi: 10.1084/jem.20091318

Yamamoto, R. et al. Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells. Cell 154, 1112–1126 (2013).

pubmed: 23993099 doi: 10.1016/j.cell.2013.08.007

Osawa, M., Hanada, K., Hamada, H. & Nakauchi, H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273, 242–245 (1996).

pubmed: 8662508 doi: 10.1126/science.273.5272.242

Dong, F. et al. Differentiation of transplanted haematopoietic stem cells tracked by single-cell transcriptomic analysis. Nat. Cell Biol. 22, 630–639 (2020).

pubmed: 32367048 doi: 10.1038/s41556-020-0512-1

Pei, W. et al. Polylox barcoding reveals haematopoietic stem cell fates realized in vivo. Nature 548, 456–460 (2017).

pubmed: 28813413 pmcid: 5905670 doi: 10.1038/nature23653

Naik, S. H. et al. Diverse and heritable lineage imprinting of early haematopoietic progenitors. Nature 496, 229–232 (2013).

pubmed: 23552896 doi: 10.1038/nature12013

Velten, L. et al. Human haematopoietic stem cell lineage commitment is a continuous process. Nat. Cell Biol. 19, 271–281 (2017).

pubmed: 28319093 pmcid: 5496982 doi: 10.1038/ncb3493

Tusi, B. K. et al. Population snapshots predict early haematopoietic and erythroid hierarchies. Nature 555, 54–60 (2018).

pubmed: 29466336 pmcid: 5899604 doi: 10.1038/nature25741

Carrelha, J. et al. Hierarchically related lineage-restricted fates of multipotent haematopoietic stem cells. Nature 554, 106–111 (2018). This study uses single-cell transplantation techniques to reveal distinct patterns of lineage bias among HSCs, which are stable upon serial transplantation.

pubmed: 29298288 doi: 10.1038/nature25455

Bowling, S. et al. An engineered CRISPR-Cas9 mouse line for simultaneous readout of lineage histories and gene expression profiles in single cells. Cell 181, 1693–1694 (2020).

pubmed: 32589959 pmcid: 7530571 doi: 10.1016/j.cell.2020.06.018

Rodriguez-Fraticelli, A. E. et al. Single-cell lineage tracing unveils a role for TCF15 in haematopoiesis. Nature 583, 585–589 (2020).

pubmed: 32669716 pmcid: 7579674 doi: 10.1038/s41586-020-2503-6

Laurenti, E. & Gottgens, B. From haematopoietic stem cells to complex differentiation landscapes. Nature 553, 418–426 (2018).

pubmed: 29364285 pmcid: 6555401 doi: 10.1038/nature25022

Paul, F. et al. Transcriptional heterogeneity and lineage commitment in myeloid progenitors. Cell 163, 1663–1677 (2015).

pubmed: 26627738 doi: 10.1016/j.cell.2015.11.013

Kang, Y. A. et al. Secretory MPP3 reinforce myeloid differentiation trajectory and amplify myeloid cell production. J. Exp. Med. 220, e20230088 (2023). This study identifies FcγR

pubmed: 37115584 pmcid: 10140385 doi: 10.1084/jem.20230088

Haas, S. et al. Inflammation-induced emergency megakaryopoiesis driven by hematopoietic stem cell-like megakaryocyte progenitors. Cell Stem Cell 17, 422–434 (2015). This study identifies a bypass mechanism by which HSCs can contribute directly to the megakaryocyte lineage under inflammatory conditions.

pubmed: 26299573 doi: 10.1016/j.stem.2015.07.007

Morcos, M. N. F. et al. Fate mapping of hematopoietic stem cells reveals two pathways of native thrombopoiesis. Nat. Commun. 13, 4504 (2022).

pubmed: 35922411 pmcid: 9349191 doi: 10.1038/s41467-022-31914-z

Grinenko, T. et al. Hematopoietic stem cells can differentiate into restricted myeloid progenitors before cell division in mice. Nat. Commun. 9, 1898 (2018).

pubmed: 29765026 pmcid: 5954009 doi: 10.1038/s41467-018-04188-7

Yanez, A. et al. Granulocyte-monocyte progenitors and monocyte-dendritic cell progenitors independently produce functionally distinct monocytes. Immunity 47, 890–902.e4 (2017).

pubmed: 29166589 pmcid: 5726802 doi: 10.1016/j.immuni.2017.10.021

Weinreb, C., Rodriguez-Fraticelli, A., Camargo, F. D. & Klein, A. M. Lineage tracing on transcriptional landscapes links state to fate during differentiation. Science 367, eaaw3381 (2020). Together with Yanez et al. (2017), this study identifies two distinct pathways for monocyte differentiation that have distinct functional characteristics.

pubmed: 31974159 pmcid: 7608074 doi: 10.1126/science.aaw3381

Busch, K. et al. Fundamental properties of unperturbed haematopoiesis from stem cells in vivo. Nature 518, 542–546 (2015). This is the first major study to reveal, using fluorescent lineage-tracing approaches, that HSCs appear to make little contribution to steady-state haematopoiesis, with most daily blood production emanating from MPPs.

pubmed: 25686605 doi: 10.1038/nature14242

Sheikh, B. N. et al. MOZ (KAT6A) is essential for the maintenance of classically defined adult hematopoietic stem cells. Blood 128, 2307–2318 (2016).

pubmed: 27663673 doi: 10.1182/blood-2015-10-676072

Challen, G. A., Pietras, E. M., Wallscheid, N. C. & Singer, R. A. J. Simplified murine multipotent progenitor isolation scheme: establishing a consensus approach for multipotent progenitor identification. Exp. Hematol. 104, 55–63 (2021).

pubmed: 34648848 doi: 10.1016/j.exphem.2021.09.007

Hofer, T. & Rodewald, H. R. Differentiation-based model of hematopoietic stem cell functions and lineage pathways. Blood 132, 1106–1113 (2018).

pubmed: 30042097 pmcid: 6307983 doi: 10.1182/blood-2018-03-791517

Chapple, R. H. et al. Lineage tracing of murine adult hematopoietic stem cells reveals active contribution to steady-state hematopoiesis. Blood Adv. 2, 1220–1228 (2018).

pubmed: 29848758 pmcid: 5998934 doi: 10.1182/bloodadvances.2018016295

Sawen, P. et al. Murine HSCs contribute actively to native hematopoiesis but with reduced differentiation capacity upon aging. eLife 7, e41528 (2018).

doi: 10.7554/eLife.41258

Sawai, C. M. et al. Hematopoietic stem cells are the major source of multilineage hematopoiesis in adult animals. Immunity 45, 597–609 (2016).

pubmed: 27590115 pmcid: 5054720 doi: 10.1016/j.immuni.2016.08.007

Scheiermann, C., Frenette, P. S. & Hidalgo, A. Regulation of leucocyte homeostasis in the circulation. Cardiovasc. Res. 107, 340–351 (2015).

pubmed: 25750191 pmcid: 4560027 doi: 10.1093/cvr/cvv099

Stark, M. A. et al. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22, 285–294 (2005).

pubmed: 15780986 doi: 10.1016/j.immuni.2005.01.011

Heo, H. R. et al. Hormonal regulation of hematopoietic stem cells and their niche: a focus on estrogen. Int. J. Stem Cell 8, 18–23 (2015).

doi: 10.15283/ijsc.2015.8.1.18

Yan, H., Baldridge, M. T. & King, K. Y. Hematopoiesis and the bacterial microbiome. Blood 132, 559–564 (2018).

pubmed: 29853538 pmcid: 6085989 doi: 10.1182/blood-2018-02-832519

King, K. Y. & Goodell, M. A. Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat. Rev. Immunol. 11, 685–692 (2011).

pubmed: 21904387 pmcid: 4154310 doi: 10.1038/nri3062

Takizawa, H. et al. Pathogen-induced TLR4-TRIF innate immune signaling in hematopoietic stem cells promotes proliferation but reduces competitive fitness. Cell Stem Cell 21, 225–240.e5 (2017).

pubmed: 28736216 doi: 10.1016/j.stem.2017.06.013

Nagai, Y. et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24, 801–812 (2006).

pubmed: 16782035 pmcid: 1626529 doi: 10.1016/j.immuni.2006.04.008

Bakker, S. T. & Passegue, E. Resilient and resourceful: genome maintenance strategies in hematopoietic stem cells. Exp. Hematol. 41, 915–923 (2013).

pubmed: 24067363 doi: 10.1016/j.exphem.2013.09.007

Blanpain, C., Mohrin, M., Sotiropoulou, P. A. & Passegue, E. DNA-damage response in tissue-specific and cancer stem cells. Cell Stem Cell 8, 16–29 (2011).

pubmed: 21211780 doi: 10.1016/j.stem.2010.12.012

Chandel, N. S., Jasper, H., Ho, T. T. & Passegue, E. Metabolic regulation of stem cell function in tissue homeostasis and organismal ageing. Nat. Cell Biol. 18, 823–832 (2016).

pubmed: 27428307 doi: 10.1038/ncb3385

Beerman, I. & Rossi, D. J. Epigenetic control of stem cell potential during homeostasis, aging, and disease. Cell Stem Cell 16, 613–625 (2015).

pubmed: 26046761 pmcid: 4469343 doi: 10.1016/j.stem.2015.05.009

Ho, T. T. et al. Autophagy maintains the metabolism and function of young and old stem cells. Nature 543, 205–210 (2017).

pubmed: 28241143 pmcid: 5344718 doi: 10.1038/nature21388

Paulson, R. F., Hariharan, S. & Little, J. A. Stress erythropoiesis: definitions and models for its study. Exp. Hematol. 89, 43–54.e2 (2020).

pubmed: 32750404 pmcid: 7508762 doi: 10.1016/j.exphem.2020.07.011

Noetzli, L. J., French, S. L. & Machlus, K. R. New insights into the differentiation of megakaryocytes from hematopoietic progenitors. Arterioscler. Thromb. Vasc. Biol. 39, 1288–1300 (2019).

pubmed: 31043076 pmcid: 6594866 doi: 10.1161/ATVBAHA.119.312129

Dancey, J. T., Deubelbeiss, K. A., Harker, L. A. & Finch, C. A. Neutrophil kinetics in man. J. Clin. Invest. 58, 705–715 (1976).

pubmed: 956397 pmcid: 333229 doi: 10.1172/JCI108517

Boettcher, S. & Manz, M. G. Regulation of inflammation- and infection-driven hematopoiesis. Trends Immunol. 38, 345–357 (2017).

pubmed: 28216309 doi: 10.1016/j.it.2017.01.004

Mayadas, T. N., Cullere, X. & Lowell, C. A. The multifaceted functions of neutrophils. Annu. Rev. Pathol. 9, 181–218 (2014).

pubmed: 24050624 doi: 10.1146/annurev-pathol-020712-164023

Manz, M. G. & Boettcher, S. Emergency granulopoiesis. Nat. Rev. Immunol. 14, 302–314 (2014).

pubmed: 24751955 doi: 10.1038/nri3660

Herault, A. et al. Myeloid progenitor cluster formation drives emergency and leukaemic myelopoiesis. Nature 544, 53–58 (2017). This study describes how GMPs form clusters that serve as hubs of expansion and differentiation during EM.

pubmed: 28355185 pmcid: 5383507 doi: 10.1038/nature21693

Olson, O. C., Kang, Y. A. & Passegue, E. Normal hematopoiesis is a balancing act of self-renewal and regeneration. Cold Spring Harb. Perspect. Med. 10, a035519 (2020).

pubmed: 31988205 pmcid: 7706583 doi: 10.1101/cshperspect.a035519

Reynaud, D. et al. IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. Cancer Cell 20, 661–673 (2011).

pubmed: 22094259 pmcid: 3220886 doi: 10.1016/j.ccr.2011.10.012

Essers, M. A. et al. IFNα activates dormant haematopoietic stem cells in vivo. Nature 458, 904–908 (2009).

pubmed: 19212321 doi: 10.1038/nature07815

Baldridge, M. T., King, K. Y., Boles, N. C., Weksberg, D. C. & Goodell, M. A. Quiescent haematopoietic stem cells are activated by IFN-γ in response to chronic infection. Nature 465, 793–797 (2010). Together with Essers et al. (2009), this study demonstrates the role of inflammatory cytokines in activating HSCs in response to stress.

pubmed: 20535209 pmcid: 2935898 doi: 10.1038/nature09135

Bernitz, J. M., Daniel, M. G., Fstkchyan, Y. S. & Moore, K. Granulocyte colony-stimulating factor mobilizes dormant hematopoietic stem cells without proliferation in mice. Blood 129, 1901–1912 (2017).

pubmed: 28179275 pmcid: 5383874 doi: 10.1182/blood-2016-11-752923

Pietras, E. M. et al. Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nat. Cell Biol. 18, 607–618 (2016).

pubmed: 27111842 pmcid: 4884136 doi: 10.1038/ncb3346

Etzrodt, M. et al. Inflammatory signals directly instruct PU.1 in HSCs via TNF. Blood 133, 816–819 (2019).

pubmed: 30301719 doi: 10.1182/blood-2018-02-832998

Yamashita, M. & Passegue, E. TNF-α coordinates hematopoietic stem cell survival and myeloid regeneration. Cell Stem Cell 25, 357–372.e7 (2019).

pubmed: 31230859 pmcid: 6733032 doi: 10.1016/j.stem.2019.05.019

Mossadegh-Keller, N. et al. M-CSF instructs myeloid lineage fate in single haematopoietic stem cells. Nature 497, 239–243 (2013).

pubmed: 23575636 pmcid: 3679883 doi: 10.1038/nature12026

Challen, G. A., Boles, N. C., Chambers, S. M. & Goodell, M. A. Distinct hematopoietic stem cell subtypes are differentially regulated by TGFβ1. Cell Stem Cell 6, 265–278 (2010).

pubmed: 20207229 pmcid: 2837284 doi: 10.1016/j.stem.2010.02.002

Bogeska, R. et al. Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging. Cell Stem Cell 29, 1273–1284 (2022).

pubmed: 35858618 pmcid: 9357150 doi: 10.1016/j.stem.2022.06.012

Miyamoto, K. et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 1, 101–112 (2007).

pubmed: 18371339 doi: 10.1016/j.stem.2007.02.001

Takubo, K. et al. Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell 12, 49–61 (2013).

pubmed: 23290136 pmcid: 6592822 doi: 10.1016/j.stem.2012.10.011

Lin, K. K. et al. CD81 is essential for the re-entry of hematopoietic stem cells to quiescence following stress-induced proliferation via deactivation of the Akt pathway. PLoS Biol. 9, e1001148 (2011).

pubmed: 21931533 pmcid: 3172193 doi: 10.1371/journal.pbio.1001148

Pietras, E. M. et al. Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. J. Exp. Med. 211, 245–262 (2014).

pubmed: 24493802 pmcid: 3920566 doi: 10.1084/jem.20131043

Sato, T. et al. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat. Med. 15, 696–700 (2009).

pubmed: 19483695 doi: 10.1038/nm.1973

Chavez, J. S. et al. PU.1 enforces quiescence and limits hematopoietic stem cell expansion during inflammatory stress. J. Exp. Med. 218, e20201169 (2021).

pubmed: 33857288 pmcid: 8056754 doi: 10.1084/jem.20201169

Hernandez, G. et al. Pro-inflammatory cytokine blockade attenuates myeloid expansion in a murine model of rheumatoid arthritis. Haematologica 105, 585–597 (2020).

pubmed: 31101752 pmcid: 7049366 doi: 10.3324/haematol.2018.197210

Beerman, I. et al. Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging. Cell Stem Cell 12, 413–425 (2013).

pubmed: 23415915 doi: 10.1016/j.stem.2013.01.017

Munz, C. M. et al. Regeneration after blood loss and acute inflammation proceeds without contribution of primitive HSCs. Blood 141, 2483–2492 (2023).

pubmed: 36787502

Fanti, A. K. et al. Flt3- and Tie2-Cre tracing identifies regeneration in sepsis from multipotent progenitors but not hematopoietic stem cells. Cell Stem Cell 30, 207–218.e7 (2023). Together with Munz et al. (2023), this study demonstrates the importance of MPPs during diverse EM responses.

pubmed: 36652946 doi: 10.1016/j.stem.2022.12.014

Baratono, S. R., Chu, N., Richman, L. P. & Behrens, E. M. Toll-like receptor 9 and interferon-γ receptor signaling suppress the B-cell fate of uncommitted progenitors in mice. Eur. J. Immunol. 45, 1313–1325 (2015).

pubmed: 25639361 pmcid: 4913483 doi: 10.1002/eji.201445319

Welner, R. S. et al. Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection. Blood 112, 3753–3761 (2008).

pubmed: 18552210 pmcid: 2572801 doi: 10.1182/blood-2008-04-151506

Kato, H. et al. Infection perturbs Bach2- and Bach1-dependent erythroid lineage ‘choice’ to cause anemia. Nat. Immunol. 19, 1059–1070 (2018).

pubmed: 30250186 doi: 10.1038/s41590-018-0202-3

Swann, J. W. et al. IL-33 promotes anemia during chronic inflammation by inhibiting differentiation of erythroid progenitors. J. Exp. Med. 217, e20200164 (2020).

pubmed: 32520308 pmcid: 7478740 doi: 10.1084/jem.20200164

Raundhal, M. et al. Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias. Nat. Immunol. 22, 520–529 (2021).

pubmed: 33753942 pmcid: 8026551 doi: 10.1038/s41590-021-00895-4

Waight, J. D. et al. Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis. J. Clin. Invest. 123, 4464–4478 (2013).

pubmed: 24091328 pmcid: 3784535 doi: 10.1172/JCI68189

Zhang, D. E. et al. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice. Proc. Natl Acad. Sci. USA 94, 569–574 (1997).

pubmed: 9012825 pmcid: 19554 doi: 10.1073/pnas.94.2.569

Lieschke, G. J. et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84, 1737–1746 (1994).

pubmed: 7521686 doi: 10.1182/blood.V84.6.1737.1737

Liu, F., Wu, H. Y., Wesselschmidt, R., Kornaga, T. & Link, D. C. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 5, 491–501 (1996).

pubmed: 8934575 doi: 10.1016/S1074-7613(00)80504-X

Hirai, H. et al. C/EBPβ is required for ‘emergency’ granulopoiesis. Nat. Immunol. 7, 732–739 (2006). This study demonstrates that the generation of neutrophils in steady state and EM uses distinct transcription factors.

pubmed: 16751774 doi: 10.1038/ni1354

Zhang, H. et al. STAT3 controls myeloid progenitor growth during emergency granulopoiesis. Blood 116, 2462–2471 (2010).

pubmed: 20581311 pmcid: 2953883 doi: 10.1182/blood-2009-12-259630

Lee, C. K. et al. STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity 17, 63–72 (2002).

pubmed: 12150892 doi: 10.1016/S1074-7613(02)00336-9

Kurotaki, D. et al. IRF8 inhibits C/EBPα activity to restrain mononuclear phagocyte progenitors from differentiating into neutrophils. Nat. Commun. 5, 4978 (2014).

pubmed: 25236377 doi: 10.1038/ncomms5978

Meyer, M. A. et al. Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance. Nat. Commun. 9, 1250 (2018).

pubmed: 29593283 pmcid: 5871846 doi: 10.1038/s41467-018-03600-6

de Bruin, A. M. et al. IFNγ induces monopoiesis and inhibits neutrophil development during inflammation. Blood 119, 1543–1554 (2012).

pubmed: 22117048 doi: 10.1182/blood-2011-07-367706

Pinho, S. & Frenette, P. S. Haematopoietic stem cell activity and interactions with the niche. Nat. Rev. Mol. Cell Biol. 20, 303–320 (2019).

pubmed: 30745579 pmcid: 6483843 doi: 10.1038/s41580-019-0103-9

Kunisaki, Y. et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 502, 637–643 (2013).

pubmed: 24107994 pmcid: 3821873 doi: 10.1038/nature12612

Bruns, I. et al. Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion. Nat. Med. 20, 1315–1320 (2014).

pubmed: 25326802 pmcid: 4258871 doi: 10.1038/nm.3707

Wu, Q. Z. et al. Resilient anatomy and local microplasticity of naïve and stress hematopoiesis. Preprint at bioRxiv https://doi.org/10.1101/2022.05.23.492315 (2022).

Zhang, J. et al. In situ mapping identifies distinct vascular niches for myelopoiesis. Nature 590, 457–462 (2021). This study identifies the vascular niches for steady state and EM, describing granulocyte production lines organized along sinusoidal vessels.

pubmed: 33568812 pmcid: 8020897 doi: 10.1038/s41586-021-03201-2

Cain, D. W., Snowden, P. B., Sempowski, G. D. & Kelsoe, G. Inflammation triggers emergency granulopoiesis through a density-dependent feedback mechanism. PLoS ONE 6, e19957 (2011).

pubmed: 21655273 pmcid: 3104996 doi: 10.1371/journal.pone.0019957

Casanova-Acebes, M. et al. Rhythmic modulation of the hematopoietic niche through neutrophil clearance. Cell 153, 1025–1035 (2013). This study identifies neutrophil clearance as a driver of circadian regulation of HSPCs in the bone marrow.

pubmed: 23706740 pmcid: 4128329 doi: 10.1016/j.cell.2013.04.040

Kanayama, M. et al. Skewing of the population balance of lymphoid and myeloid cells by secreted and intracellular osteopontin. Nat. Immunol. 18, 973–984 (2017).

pubmed: 28671690 pmcid: 5568448 doi: 10.1038/ni.3791

Grassinger, J. et al. Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with α

pubmed: 19417209 doi: 10.1182/blood-2009-01-197988

Nilsson, S. K. et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106, 1232–1239 (2005).

pubmed: 15845900 doi: 10.1182/blood-2004-11-4422

Stier, S. et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 201, 1781–1791 (2005).

pubmed: 15928197 pmcid: 2213260 doi: 10.1084/jem.20041992

Zhu, J. et al. Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. Blood 109, 3706–3712 (2007).

pubmed: 17227831 doi: 10.1182/blood-2006-08-041384

Haltalli, M. L. R. et al. Manipulating niche composition limits damage to haematopoietic stem cells during Plasmodium infection. Nat. Cell Biol. 22, 1399–1410 (2020).

pubmed: 33230302 pmcid: 7611033 doi: 10.1038/s41556-020-00601-w

Basu, S., Zhang, H. H., Quilici, C. & Dunn, A. R. Candida albicans can stimulate stromal cells resulting in enhanced granulopoiesis. Stem Cell Dev. 13, 39–50 (2004).

doi: 10.1089/154732804773099245

Boettcher, S. et al. Endothelial cells translate pathogen signals into G-CSF-driven emergency granulopoiesis. Blood 124, 1393–1403 (2014).

pubmed: 24990886 pmcid: 4148762 doi: 10.1182/blood-2014-04-570762

Boettcher, S. et al. Cutting edge: LPS-induced emergency myelopoiesis depends on TLR4-expressing nonhematopoietic cells. J. Immunol. 188, 5824–5828 (2012). Together with Boettcher et al. (2014), this study identifies the critical role of bone marrow endothelial cells in sensing LPS and secreting cytokines to activate EM in HSPCs.

pubmed: 22586037 doi: 10.4049/jimmunol.1103253

Andonegui, G. et al. Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J. Clin. Invest. 111, 1011–1020 (2003).

pubmed: 12671050 pmcid: 152584 doi: 10.1172/JCI16510

Zhan, Y., Lieschke, G. J., Grail, D., Dunn, A. R. & Cheers, C. Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice. Blood 91, 863–869 (1998).

pubmed: 9446646 doi: 10.1182/blood.V91.3.863

Basu, S. et al. “Emergency” granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection. Blood 95, 3725–3733 (2000).

pubmed: 10845903 doi: 10.1182/blood.V95.12.3725.012k06_3725_3733

Heidt, T. et al. Chronic variable stress activates hematopoietic stem cells. Nat. Med. 20, 754–758 (2014).

pubmed: 24952646 pmcid: 4087061 doi: 10.1038/nm.3589

Tang, Y. et al. Norepinephrine modulates myelopoiesis after experimental thermal injury with sepsis. Ann. Surg. 233, 266–275 (2001).

pubmed: 11176134 pmcid: 1421210 doi: 10.1097/00000658-200102000-00017

Maestroni, G. J., Togni, M. & Covacci, V. Norepinephrine protects mice from acute lethal doses of carboplatin. Exp. Hematol. 25, 491–494 (1997).

pubmed: 9197326

Vasamsetti, S. B. et al. Sympathetic neuronal activation triggers myeloid progenitor proliferation and differentiation. Immunity 49, 93–106.e7 (2018).

pubmed: 29958804 pmcid: 6051926 doi: 10.1016/j.immuni.2018.05.004

Askenase, M. H. et al. Bone-marrow-resident NK cells prime monocytes for regulatory function during infection. Immunity 42, 1130–1142 (2015).

pubmed: 26070484 pmcid: 4472558 doi: 10.1016/j.immuni.2015.05.011

Rosen, H., Gordon, S. & North, R. J. Exacerbation of murine listeriosis by a monoclonal antibody specific for the type 3 complement receptor of myelomonocytic cells: absence of monocytes at infective foci allows Listeria to multiply in nonphagocytic cells. J. Exp. Med. 170, 27–37 (1989).

pubmed: 2501445 doi: 10.1084/jem.170.1.27

Serbina, N. V., Hohl, T. M., Cherny, M. & Pamer, E. G. Selective expansion of the monocytic lineage directed by bacterial infection. J. Immunol. 183, 1900–1910 (2009).

pubmed: 19596996 doi: 10.4049/jimmunol.0900612

Beshara, R. et al. Alteration of Flt3-ligand-dependent de novo generation of conventional dendritic cells during influenza infection contributes to respiratory bacterial superinfection. PLoS Pathog. 14, e1007360 (2018). This study shows how adaptation of the haematopoietic system to one perturbation actually decreases its ability to respond to other stimuli, highlighting the importance of specificity in EM responses and the evolutionary cost of EM mechanisms.

pubmed: 30372491 pmcid: 6224179 doi: 10.1371/journal.ppat.1007360

Karsunky, H., Merad, M., Cozzio, A., Weissman, I. L. & Manz, M. G. Flt3 ligand regulates dendritic cell development from Flt3

pubmed: 12874263 pmcid: 2194067 doi: 10.1084/jem.20030323

Pedersen, S. F. & Ho, Y. C. SARS-CoV-2: a storm is raging. J. Clin. Invest. 130, 2202–2205 (2020).

pubmed: 32217834 pmcid: 7190904 doi: 10.1172/JCI137647

Merad, M. & Martin, J. C. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat. Rev. Immunol. 20, 355–362 (2020).

pubmed: 32376901 pmcid: 7201395 doi: 10.1038/s41577-020-0331-4

Barnes, B. J. et al. Targeting potential drivers of COVID-19: neutrophil extracellular traps. J. Exp. Med. 217, e20200652 (2020).

pubmed: 32302401 pmcid: 7161085 doi: 10.1084/jem.20200652

Cao, X. COVID-19: immunopathology and its implications for therapy. Nat. Rev. Immunol. 20, 269–270 (2020).

pubmed: 32273594 pmcid: 7143200 doi: 10.1038/s41577-020-0308-3

Wilk, A. J. et al. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19. J. Exp. Med. 218, e20210582 (2021).

pubmed: 34128959 pmcid: 8210586 doi: 10.1084/jem.20210582

Wang, X. et al. Dysregulated hematopoiesis in bone marrow marks severe COVID-19. Cell Discov. 7, 60 (2021). This study identifies activation of EM in HSPCs as a marker of severe COVID-19.

pubmed: 34349096 pmcid: 8335717 doi: 10.1038/s41421-021-00296-9

Silvin, A. et al. Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19. Cell 182, 1401–1418.e18 (2020).

pubmed: 32810439 pmcid: 7405878 doi: 10.1016/j.cell.2020.08.002

Wilson, J. G. et al. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis. JCI Insight 5, e140289 (2020).

pubmed: 32706339 pmcid: 7526438 doi: 10.1172/jci.insight.140289

Cabrera, L. E. et al. Characterization of low-density granulocytes in COVID-19. PLoS Pathog. 17, e1009721 (2021).

pubmed: 34228753 pmcid: 8284631 doi: 10.1371/journal.ppat.1009721

Schultze, J. L. & Aschenbrenner, A. C. COVID-19 and the human innate immune system. Cell 184, 1671–1692 (2021).

pubmed: 33743212 pmcid: 7885626 doi: 10.1016/j.cell.2021.02.029

Quail, D. F. et al. Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF. Nat. Cell Biol. 19, 974–987 (2017).

pubmed: 28737771 pmcid: 6759922 doi: 10.1038/ncb3578

Nagareddy, P. R. et al. Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell Metab. 19, 821–835 (2014).

pubmed: 24807222 pmcid: 4048939 doi: 10.1016/j.cmet.2014.03.029

Luo, Y. et al. Microbiota from obese mice regulate hematopoietic stem cell differentiation by altering the bone niche. Cell Metab. 22, 886–894 (2015).

pubmed: 26387866 doi: 10.1016/j.cmet.2015.08.020

Nagareddy, P. R. et al. Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metab. 17, 695–708 (2013).

pubmed: 23663738 pmcid: 3992275 doi: 10.1016/j.cmet.2013.04.001

Edgar, L. et al. Hyperglycemia induces trained immunity in macrophages and their precursors and promotes atherosclerosis. Circulation 144, 961–982 (2021). Together with Nagareddy et al. (2013), this study demonstrates how systemic metabolic disease can activate EM and induce central trained immunity.

pubmed: 34255973 pmcid: 8448412 doi: 10.1161/CIRCULATIONAHA.120.046464

Regan-Komito, D. et al. GM-CSF drives dysregulated hematopoietic stem cell activity and pathogenic extramedullary myelopoiesis in experimental spondyloarthritis. Nat. Commun. 11, 155 (2020).

pubmed: 31919358 pmcid: 6952438 doi: 10.1038/s41467-019-13853-4

Al-Mossawi, M. H. et al. Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis. Nat. Commun. 8, 1510 (2017).

pubmed: 29142230 pmcid: 5688161 doi: 10.1038/s41467-017-01771-2

Cortez-Retamozo, V. et al. Origins of tumor-associated macrophages and neutrophils. Proc. Natl Acad. Sci. USA 109, 2491–2496 (2012).

pubmed: 22308361 pmcid: 3289379 doi: 10.1073/pnas.1113744109

Franklin, R. A. et al. The cellular and molecular origin of tumor-associated macrophages. Science 344, 921–925 (2014).

pubmed: 24812208 pmcid: 4204732 doi: 10.1126/science.1252510

Leach, J., Morton, J. P. & Sansom, O. J. Neutrophils: homing in on the myeloid mechanisms of metastasis. Mol. Immunol. 110, 69–76 (2019).

pubmed: 29269005 pmcid: 6544568 doi: 10.1016/j.molimm.2017.12.013

Engblom, C. et al. Osteoblasts remotely supply lung tumors with cancer-promoting SiglecF(high) neutrophils. Science 358, eaal5081 (2017).

pubmed: 29191879 pmcid: 6343476 doi: 10.1126/science.aal5081

Hao, X. et al. Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal. Cell Stem Cell 30, 648–664.e8 (2023). Together with Engblom et al. (2017), this study identifies the role of activated bone marrow stromal cells in driving pathogenic EM activation during cancer.

pubmed: 37146584 doi: 10.1016/j.stem.2023.04.005

Lin, E. Y., Nguyen, A. V., Russell, R. G. & Pollard, J. W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193, 727–740 (2001).

pubmed: 11257139 pmcid: 2193412 doi: 10.1084/jem.193.6.727

Wculek, S. K. & Malanchi, I. Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature 528, 413–417 (2015).

pubmed: 26649828 pmcid: 4700594 doi: 10.1038/nature16140

Kowanetz, M. et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G

pubmed: 21081700 pmcid: 3003076 doi: 10.1073/pnas.1015855107

McAllister, S. S. et al. Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 133, 994–1005 (2008). This study demonstrates the role of tumour-activated myelopoiesis in creating a tumour-promoting systemic environment.

pubmed: 18555776 pmcid: 4121664 doi: 10.1016/j.cell.2008.04.045

Coffelt, S. B. et al. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522, 345–348 (2015).

pubmed: 25822788 pmcid: 4475637 doi: 10.1038/nature14282

Consonni, F. M. et al. Heme catabolism by tumor-associated macrophages controls metastasis formation. Nat. Immunol. 22, 595–606 (2021).

pubmed: 33903766 doi: 10.1038/s41590-021-00921-5

Koelwyn, G. J. et al. Myocardial infarction accelerates breast cancer via innate immune reprogramming. Nat. Med. 26, 1452–1458 (2020).

pubmed: 32661390 pmcid: 7789095 doi: 10.1038/s41591-020-0964-7

Hughes, R. et al. Perivascular M2 macrophages stimulate tumor relapse after chemotherapy. Cancer Res. 75, 3479–3491 (2015).

pubmed: 26269531 pmcid: 5024531 doi: 10.1158/0008-5472.CAN-14-3587

Shree, T. et al. Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer. Genes Dev. 25, 2465–2479 (2011).

pubmed: 22156207 pmcid: 3243057 doi: 10.1101/gad.180331.111

DeNardo, D. G. et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov. 1, 54–67 (2011).

pubmed: 22039576 pmcid: 3203524 doi: 10.1158/2159-8274.CD-10-0028

Marigo, I. et al. Tumor-induced tolerance and immune suppression depend on the C/EBPβ transcription factor. Immunity 32, 790–802 (2010).

pubmed: 20605485 doi: 10.1016/j.immuni.2010.05.010

Pylayeva-Gupta, Y., Lee, K. E., Hajdu, C. H., Miller, G. & Bar-Sagi, D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 21, 836–847 (2012).

pubmed: 22698407 pmcid: 3721510 doi: 10.1016/j.ccr.2012.04.024

Strauss, L. et al. RORC1 regulates tumor-promoting “emergency” granulo-monocytopoiesis. Cancer Cell 28, 253–269 (2015).

pubmed: 26267538 doi: 10.1016/j.ccell.2015.07.006

Strauss, L. et al. Targeted deletion of PD-1 in myeloid cells induces antitumor immunity. Sci. Immunol. 5, eaay1863 (2020).

pubmed: 31901074 pmcid: 7183328 doi: 10.1126/sciimmunol.aay1863

Kaufmann, E. et al. BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell 172, 176–190.e19 (2018).

pubmed: 29328912 doi: 10.1016/j.cell.2017.12.031

Verovskaya, E. V., Dellorusso, P. V. & Passegue, E. Losing sense of self and surroundings: hematopoietic stem cell aging and leukemic transformation. Trends Mol. Med. 25, 494–515 (2019).

pubmed: 31109796 pmcid: 7657013 doi: 10.1016/j.molmed.2019.04.006

Kwok, A. J. et al. Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsis. Nat. Immunol. 24, 767–779 (2023).

pubmed: 37095375 doi: 10.1038/s41590-023-01490-5

Hirschhorn, D. et al. T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants. Cell 186, 1432–1447.e17 (2023).

pubmed: 37001503 doi: 10.1016/j.cell.2023.03.007

Gungabeesoon, J. et al. A neutrophil response linked to tumor control in immunotherapy. Cell 186, 1448–1464.e20 (2023).

pubmed: 37001504 doi: 10.1016/j.cell.2023.02.032

Mauer, A. M. Diurnal variation of proliferative activity in the human bone marrow. Blood 26, 1–7 (1965).

pubmed: 14314397 doi: 10.1182/blood.V26.1.1.1

Ohdo, S. et al. Chronopharmacology of granulocyte colony-stimulating factor in mice. J. Pharmacol. Exp. Ther. 285, 242–246 (1998).

pubmed: 9536017

Lucas, D., Battista, M., Shi, P. A., Isola, L. & Frenette, P. S. Mobilized hematopoietic stem cell yield depends on species-specific circadian timing. Cell Stem Cell 3, 364–366 (2008).

pubmed: 18940728 pmcid: 4089094 doi: 10.1016/j.stem.2008.09.004

Mendez-Ferrer, S., Lucas, D., Battista, M. & Frenette, P. S. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 452, 442–447 (2008).

pubmed: 18256599 doi: 10.1038/nature06685

Golan, K. et al. Daily onset of light and darkness differentially controls hematopoietic stem cell differentiation and maintenance. Cell Stem Cell 23, 572–585.e7 (2018).

pubmed: 30174297 doi: 10.1016/j.stem.2018.08.002

Olsson, A. et al. Single-cell analysis of mixed-lineage states leading to a binary cell fate choice. Nature 537, 698–702 (2016).

pubmed: 27580035 pmcid: 5161694 doi: 10.1038/nature19348

Puram, R. V. et al. Core circadian clock genes regulate leukemia stem cells in AML. Cell 165, 303–316 (2016).

pubmed: 27058663 pmcid: 4826477 doi: 10.1016/j.cell.2016.03.015

Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375–388 (2020).

pubmed: 32132681 pmcid: 7186935 doi: 10.1038/s41577-020-0285-6

Mitroulis, I. et al. Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell 172, 147–161.e12 (2018). This study identifies the importance of alterations in myeloid progenitors in trained immunity of downstream myeloid cells.

pubmed: 29328910 pmcid: 5766828 doi: 10.1016/j.cell.2017.11.034

de Laval, B. et al. C/EBPβ-dependent epigenetic memory induces trained immunity in hematopoietic stem cells. Cell Stem Cell 26, 793 (2020).

pubmed: 32386557 doi: 10.1016/j.stem.2020.03.014

Hormaechea-Agulla, D. et al. Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling. Cell Stem Cell 28, 1428–1442.e6 (2021). This study demonstrates the role of inflammatory cytokines in driving clonal expansion of HSCs with pre-leukaemic mutations.

pubmed: 33743191 pmcid: 8349829 doi: 10.1016/j.stem.2021.03.002

Avagyan, S. et al. Resistance to inflammation underlies enhanced fitness in clonal hematopoiesis. Science 374, 768–772 (2021).

pubmed: 34735227 doi: 10.1126/science.aba9304

Caiado, F. et al. Aging drives Tet2

pubmed: 36379023 doi: 10.1182/blood.2022016835

Meisel, M. et al. Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature 557, 580–584 (2018).

pubmed: 29769727 pmcid: 6238954 doi: 10.1038/s41586-018-0125-z

Fuster, J. J. et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 355, 842–847 (2017).

pubmed: 28104796 pmcid: 5542057 doi: 10.1126/science.aag1381

Zhang, Q. et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 525, 389–393 (2015).

pubmed: 26287468 pmcid: 4697747 doi: 10.1038/nature15252

Mitchell, C. A. et al. Stromal niche inflammation mediated by IL-1 signalling is a targetable driver of haematopoietic ageing. Nat. Cell Biol. 25, 30–41 (2023).

pubmed: 36650381 pmcid: 7614279 doi: 10.1038/s41556-022-01053-0

Yamashita, M., Dellorusso, P. V., Olson, O. C. & Passegue, E. Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis. Nat. Rev. Cancer 20, 365–382 (2020).

pubmed: 32415283 pmcid: 7658795 doi: 10.1038/s41568-020-0260-3

Made to order: emergency myelopoiesis and demand-adapted innate immune cell production.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Informations de copyright

Références

Auteurs

James W Swann (JW)

Oakley C Olson (OC)

Emmanuelle Passegué (E)

Classifications MeSH